207 related articles for article (PubMed ID: 21653991)
1. Pharmacoepidemiology in the postmarketing assessment of the safety and efficacy of drugs in older adults.
Hilmer SN; Gnjidic D; Abernethy DR
J Gerontol A Biol Sci Med Sci; 2012 Feb; 67(2):181-8. PubMed ID: 21653991
[TBL] [Abstract][Full Text] [Related]
2. Evolving paradigms in pharmacovigilance.
Brewster W; Gibbs T; Lacroix K; Murray A; Tydeman M; Almenoff J
Curr Drug Saf; 2006 May; 1(2):127-34. PubMed ID: 18690923
[TBL] [Abstract][Full Text] [Related]
3. Safety monitoring of new anti-malarials in immediate post-marketing phase.
Edwards IR
Med Trop (Mars); 1998; 58(3 Suppl):93-6. PubMed ID: 10212911
[TBL] [Abstract][Full Text] [Related]
4. The role of databases in drug postmarketing surveillance.
Rodriguez EM; Staffa JA; Graham DJ
Pharmacoepidemiol Drug Saf; 2001; 10(5):407-10. PubMed ID: 11802586
[TBL] [Abstract][Full Text] [Related]
5. [French system of drug surveillance].
Imbs JL; Castot A; Begaud B; Larousse C; Blayac JP; Alexandre JM
Bull Acad Natl Med; 1998; 182(7):1383-91; discussion 1392-3. PubMed ID: 9916332
[TBL] [Abstract][Full Text] [Related]
6. [Study on method on post-marketing traditonal Chinese medicine safety assessment].
Kou Q; Zhao S; Feng G; Xie Y
Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2771-5. PubMed ID: 22292361
[TBL] [Abstract][Full Text] [Related]
7. The role of pharmacoepidemiology research in postmarketing surveillance and anesthesia practice/critical care medicine.
Grasela TH; Watkins WD; Hug CC; McLeskey CH; Nahrwold ML; Roizen MF; Stanley TH; Thisted RA; Walawander CA; White PF
Anesth Analg; 1993 Oct; 77(4 Suppl):S44-50. PubMed ID: 8214697
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B vaccination and multiple sclerosis: a data mining perspective.
Hauben M; Sakaguchi M; Patadia V; M Gerrits C
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):943-5. PubMed ID: 17636551
[No Abstract] [Full Text] [Related]
9. Postmarketing surveillance versus clinical trials: which benefits the patient?
Lawson DH
Cardiology; 1994; 85 Suppl 1():18-23. PubMed ID: 7743530
[TBL] [Abstract][Full Text] [Related]
10. Pharmacoepidemiologic research in Australia: challenges and opportunities for monitoring patients with rheumatic diseases.
Lu CY
Clin Rheumatol; 2009 Apr; 28(4):371-7. PubMed ID: 19190976
[TBL] [Abstract][Full Text] [Related]
11. Use of health care databases in pharmacoepidemiology.
Hennessy S
Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):311-3. PubMed ID: 16611207
[TBL] [Abstract][Full Text] [Related]
12. A review of risk measures in pharmacoepidemiology with tips for statisticians in the pharmaceutical industry.
Quartey G; Wang J; Kim J
Pharm Stat; 2011; 10(6):548-53. PubMed ID: 22127819
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacoepidemiology. An unappreciated tool].
Vasen W; Fiorentino RM
Medicina (B Aires); 2006; 66(3):257-62. PubMed ID: 16871916
[TBL] [Abstract][Full Text] [Related]
14. Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making.
Etminan M; Gill S; Fitzgerald M; Samii A
J Clin Pharmacol; 2006 Jan; 46(1):6-9. PubMed ID: 16397278
[TBL] [Abstract][Full Text] [Related]
15. Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods.
Montastruc JL; Sommet A; Lacroix I; Olivier P; Durrieu G; Damase-Michel C; Lapeyre-Mestre M; Bagheri H
Joint Bone Spine; 2006 Dec; 73(6):629-32. PubMed ID: 17110152
[No Abstract] [Full Text] [Related]
16. [Drug surveillance: concepts, objectives, and methods].
Susano RC; Laborinho Fialho L; de Quirós JF
Acta Med Port; 1992 Dec; 5(11):595-602. PubMed ID: 1293954
[TBL] [Abstract][Full Text] [Related]
17. Reports of hyperkalemia after publication of RALES--a pharmacovigilance study.
Hauben M; Reich L; Gerrits CM
Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):775-83. PubMed ID: 16804951
[TBL] [Abstract][Full Text] [Related]
18. Pharmacoepidemiology and gastroenterology: a close couple.
Leufkens HG
Scand J Gastroenterol Suppl; 2000; (232):105-8. PubMed ID: 11232486
[TBL] [Abstract][Full Text] [Related]
19. What can we really learn from observational studies?: the need for empirical assessment of methodology for active drug safety surveillance and comparative effectiveness research.
Madigan D; Ryan P
Epidemiology; 2011 Sep; 22(5):629-31. PubMed ID: 21811110
[No Abstract] [Full Text] [Related]
20. [The need for 'postmarketing surveillance'].
Stricker BH; in 't Veld BA; Feenstra J
Ned Tijdschr Geneeskd; 1999 Apr; 143(14):711-3. PubMed ID: 10347624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
